Improved endpoints for cancer immunotherapy trials.
Hoos A, Eggermont AM, Janetzki S, Hodi FS, Ibrahim R, Anderson A, Humphrey R, Blumenstein B, Old L, Wolchok J.
Hoos A, et al. Among authors: blumenstein b.
J Natl Cancer Inst. 2010 Sep 22;102(18):1388-97. doi: 10.1093/jnci/djq310. Epub 2010 Sep 8.
J Natl Cancer Inst. 2010.
PMID: 20826737
Free PMC article.
Review.